肾综合征出血热患者不同临床阶段炎性指标的变化

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (909 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the regularity of dynamic changes of such inflammatory indexes as PCT and CRP and the changes of T-lymphocyte subsets in patients with hemorrhagic fever of renal syndrome(HFRS).Methods Data on the history of epidemiology, levels of PCT, CRP and T-lymphocyte subsets of patients with HFRS treated between 2011 and 2014 was collected for statistical analysis.Results Ninety-one patients with HFRS were included in this study. PCT and CRP levels increased significantly in the early stage, gradually declined in the polyuria phase and recovery phase. The more severe the disease was, the higher the levels of PCT and CRP were. During the early, middle and late stages, the difference in PCT was statistically significant (P<0.001). The difference in PCT between different groups of patients was also statistically significant (P<0.05). The difference of CRP was statistically significant between the three stages(P<0.001). With the exception of the severe type and critically severe group, the difference of CRP between the other groups was statistically significant (P<0.05). In the early stage of HFRS, the number of CD4⁺T lymphocytes was decreased while the number of CD8⁺T cells was increased, and the CD4/CD8 ratio was reduced.Conclusions Early detection of PCT and CRP may help to assess the severity of disease. The possible ratio imbalance in T-lymphocyte subsets in patients with hemorrhagic fever of renal syndrome may provide useful information for clinicians in the assessment and prognosis of disease.

Key words： hemorrhagic fever with renal syndrome inflammatory indexes procalcitonin C-reactive protein T-lymphocyte subsets

Received: 06 August 2019

ZTFLH:

R512.8

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FU Xiaokang
	TIAN Geng

Cite this article:

FU Xiaokang,TIAN Geng. Inflammatory markers in patients with hemorrhagic fever of renal syndrome[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(12): 1032-1036.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2019/V30/I12/1032

[1]	Chen Z H, Qin X C, Song R, et al. Co-circulation of multiple hemorrhagic fever diseases with distinct clinical characteristics in Dandong, China[J]. PLoS One, 2014, 9(2): e89896.
[2]	邓丽宁,侯宏波,李纯平. 肾综合征出血热多尿期高血压242例[J]. 武警医学, 2013, 24(11): 982-983.
[3]	Fang L Q, Goeijenbier M, Zuo S Q, et al. The association between hantavirus infection and selenium deficiency in mainland China[J]. Viruses, 2015, 7(1): 333-351.
[4]	Wang C Q, Gao J H, Li M. Co-circulation of Hantaan, Kenkeme, and Khabarovsk Hantaviruses in Bolshoy Ussuriysky Island, China[J]. Virus Res. 2014, 191: 51-58.
[5]	Song G. Epidemiological progresses of hemorrhagic fever with renal syndrome in China[J]. Chin Med J, 1999, 112(5): 472-477.
[6]	Zhang S, Wang S, Yin W, et al.Epidemic characteristics of hemorrhagic fever with renal syndrome in china, 2006-2012[J]. BMC Infect Dis, 2014, 14(1): 384.
[7]	陕西省卫生健康委员会, 空军军医大学唐都医院. 肾综合征出血热诊疗陕西省专家共识[J]. 陕西医学杂志, 2019, 48(3): 275-288.
[8]	刘凤玲,祝峰,许璐,等. 降钙素原、C反应蛋白及血常规对77例早期细菌感染的联合检测[J]. 武警医学, 2018, 29(3): 299-300.
[9]	王彦杰,冯学亮,张瑞. CRP检测在汉坦病毒感染的肾病综合征出血热患者诊断中的临床价值[J]. 中国实验诊断学, 2017, 21(8): 1369-1371.
[10]	Pal E, Korva M, Resman Rus K, et al. Sequential assessment of clinical and laboratory parameters in patients with hemorrhagic fever with renal syndrome[J]. PLoS One, 2018,13(5): e0197661.
[11]	袁明娟,黄彦,刘珊,等. 降钙素原对肾综合征出血热的早期诊断及预后作用[J]. 中华传染病杂志, 2014, 32(3): 169-170.
[12]	Jereb M, Lunaek N K, Kotar T, et al. Procalcitonin in hantavirus infections [J]. Scand J Clin Lab Invest, 2011, 71(4): 287-291.
[13]	韦志平,张胥磊,王荣华,等. 肾综合征出血热患者血清降钙素原、B-钠尿肽水平的变化及意义[J]. 实用临床医药杂志, 2016, 20(23): 160-161.
[14]	Park J H, Kim D H, Jang H R, et al. Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross sectional study[J]. Critical Care, 2014, 18: 640.
[15]	向攀,赵红心,王芳,等. 肾综合征出血热患者降钙素原测定的临床价值[J]. 中华实验和临床感染病杂志(电子版), 2015, 9(6): 28-30.
[16]	李巧玲. 肾综合征出血热患者预后影响因素分析及预警性干预对策[J]. 中国地方病防治杂志, 2016, 31(6): 690-691.
[17]	王艳军,雷海云,张小丽. 血清C反应蛋白和降钙素原对小儿急性阑尾炎的诊断价值[J]. 武警医学, 2016, 27(12): 1218-1220.
[18]	朱名超,黄银娥,朱娅,等. 肾综合征出血热患者血清降钙素原、超敏C-反应蛋白、D-二聚体及血小板检测的临床分析[J]. 检验医学与临床, 2019, 16(15): 2185-2187.
[19]	Outinen T K, Mäkelä S M, Ala-Houhala I O, et al. The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations [J]. BMC Infect Dis, 2010, 10: 132.
[20]	Macé G, Henaff M, Gobenceaux A , et al. Authors reply: Distinguishing between hantavirus-induced haemorrhagic fever with renal syndrome and pregnancy-induced liver pathologies (AFLP and HELLP syndromes) [J]. Euro Surveill, 2013,18(22): 232-236.
[21]	Payen D, Monneret G, Hotchkiss R. Immunotherapy - a potential new way forward in the treatment of sepsis[J]. Crit Care, 2013, 17(1): 118.
[22]	刘慧琳,刘桂花,田兆兴. 脓毒症患者血中淋巴细胞水平的变化[J]. 中华危重病急救医学, 2014, 26(3): 148-152.
[23]	Nie S T, Li Q, Wang H Y. Analysis of CD4+CD25+Foxp3+ regulatory T cells in patients of haemorrhagic fever with renal syndrome[J]. Zhonghua Yi Xue Za Zhi, 2009, 89(12): 817-819.
[24]	罗敏,饶明清,刘易林. 脓毒症患者T细胞亚群与降钙素的相关性分析[J]. 中国临床实用医学, 2016 (1): 64-65.
[25]	孙成栋,刘斯,李真,等. 医院获得性肺炎重症患者辅助性T细胞亚群和降钙素原变化及相关性分析[J]. 中华危重病急救医学, 2012, 24(2): 100-103.